NEAL KLEIMAN to Proportional Hazards Models
This is a "connection" page, showing publications NEAL KLEIMAN has written about Proportional Hazards Models.
Connection Strength
0.310
-
Trends and Outcomes of Off-label Use of Transcatheter Aortic Valve Replacement: Insights From the NCDR STS/ACC TVT Registry. JAMA Cardiol. 2017 08 01; 2(8):846-854.
Score: 0.082
-
Neurological Events Following Transcatheter Aortic Valve Replacement and Their Predictors: A Report From the CoreValve Trials. Circ Cardiovasc Interv. 2016 09; 9(9).
Score: 0.077
-
Clinical Implications of Physical Function and Resilience in Patients Undergoing Transcatheter Aortic Valve Replacement. J Am Heart Assoc. 2020 09; 9(17):e017075.
Score: 0.025
-
Association Between Transcatheter Aortic Valve Replacement and Early Postprocedural Stroke. JAMA. 2019 06 18; 321(23):2306-2315.
Score: 0.023
-
Prosthesis-patient mismatch in high-risk patients with severe aortic stenosis: A randomized trial of a self-expanding prosthesis. J Thorac Cardiovasc Surg. 2016 Apr; 151(4):1014-22, 1023.e1-3.
Score: 0.018
-
Prognostic significance of bleeding location and severity among patients with acute coronary syndromes. JACC Cardiovasc Interv. 2013 Jul; 6(7):709-17.
Score: 0.015
-
Repeat revascularization after contemporary percutaneous coronary intervention: an evaluation of staged, target lesion, and other unplanned revascularization procedures during the first year. Circ Cardiovasc Interv. 2012 Dec; 5(6):772-82.
Score: 0.015
-
Prognostic impact of periprocedural bleeding and myocardial infarction after percutaneous coronary intervention in unselected patients: results from the EVENT (evaluation of drug-eluting stents and ischemic events) registry. JACC Cardiovasc Interv. 2009 Nov; 2(11):1074-82.
Score: 0.012
-
In-hospital and 1-year outcomes among unselected percutaneous coronary intervention patients treated with either sirolimus- or paclitaxel-eluting stents: results from the EVENT (Evaluation of Drug Eluting Stents and Ischemic Events) registry. JACC Cardiovasc Interv. 2009 Aug; 2(8):767-75.
Score: 0.012
-
Multivessel drug-eluting stenting and impact of diabetes mellitus--a report from the EVENT registry. Catheter Cardiovasc Interv. 2009 Jun 01; 73(7):874-80.
Score: 0.012
-
Prediction of one-year survival in high-risk patients with acute coronary syndromes: results from the SYNERGY trial. J Gen Intern Med. 2008 Mar; 23(3):310-6.
Score: 0.011
-
Aspirin dose and six-month outcome after an acute coronary syndrome. J Am Coll Cardiol. 2004 Mar 17; 43(6):972-8.
Score: 0.008